HemaSphere
(Dec 2021)
Azacytidine Treatment for VEXAS Syndrome
- Marc H. G. P. Raaijmakers,
- Maud Hermans,
- Anna Aalbers,
- Melissa Rijken,
- Virgil A. S. H. Dalm,
- Paul van Daele,
- Peter J. M. Valk
Affiliations
- Marc H. G. P. Raaijmakers
- 1 Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands
- Maud Hermans
- 2 Department of Internal Medicine, Division of Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Anna Aalbers
- 1 Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands
- Melissa Rijken
- 1 Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands
- Virgil A. S. H. Dalm
- 2 Department of Internal Medicine, Division of Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Paul van Daele
- 2 Department of Internal Medicine, Division of Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands
- Peter J. M. Valk
- 1 Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands
- DOI
-
https://doi.org/10.1097/HS9.0000000000000661
- Journal volume & issue
-
Vol. 5,
no. 12
p.
e661
WeChat QR code